Navigation Links
Economy Tracheostomy Care Tray

ProductsEconomy Tracheostomy Care Tray
Company Portex
Item Economy Tracheostomy Care Tray
Features 
  • Self-contained trays offer the convenience of quick access to wound care items for the routine care of tracheostomized patients.
  • All trays are packed sterile. Custom tray configurations are available by special order.
  • 20 units per case.
Description Self-contained kits provide convenience and cost control.

Our full range of tracheostomy care trays offer a variety of wound dressing components for the effective care and management of the tracheostomized patient.

Tray configurations include full trays, economy trays, and trays with disposable inner cannula for both rigid and flexible D.I.C.® tracheostomy tubes.
Info Portex
Customer Service: (603) 352-3812
Web site: http://www.smiths-medical.com

Related medicine products :

1. Precision Economy Incubators 3EM
2. Precision Economy Incubators 5EM
3. Precision Economy Incubators 2EG
4. Precision Economy Incubators 3EG
5. Precision Economy Incubators 5EG
6. Schiotz Tonometer Certified Calibration (Economy Model)
7. Economy
8. Economy Tie
9. Economy Velcro
10. Economy Buckle
11. Economy Coat
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes.
...aspiration holes and additional electrode tip insu...recise dissection with decreased risk of collatera... design options allow the choice between retractab...designs. Optimize specific surgical demands safely...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so
Medicine Products:
(Date:12/3/2008)... Dec. 3 Ten students pu...sey will receive $5,000 and $2,000 scholarships fr...at the Fifth Annual Hispanic Health Professional S... New York Marriott Marquis Hotel. , , The ... Foundation, who donated $15,000 for $5,000 awards...
(Date:12/3/2008)...E, R.I., Dec. 3 Blue Cross & B...England (CNE) today announced that they have,reac...CNE will remain in the,BCBSRI network until 2013....,Women & Infants, and Butler) and the VNA of...esident and CEO James E. Purcell, "These are,chal...
(Date:12/3/2008)...Dec. 3 A patient who was surgicall... product, for an off-label use promoted,by Medtro...ling, according to,James A. Dunlap Jr. & Asso...it,in California along with another national law ...things, that Medtronic improperly,promoted its In...
(Date:12/3/2008)...dy suggests the procedure impairs healthy immune r... News) -- Children born by Caesarean section are a...earchers, who conducted long-term monitoring of th... By the time they were 8 years old, 362 (12.4 perc...a for which they,d been prescribed inhaled steroid...
Breaking Medicine News(10 mins):Health News:NHHF Scholarship Program Targets Growing Demand for Diversity Among Health Care Professionals 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:C-Section Might Boost Baby's Asthma Risk 2
... Human Services (HHS) and its Centers for Disease ...Infant Immunization Week (NIIW) with events// Apri...the United States are expected to participate in N...ng the importance of timely infant and childhood v...
...parent failure by official bodies to halt the dist...ies have been incidents caused by E. coli contami...as well as pet food. Around 200 persons were aff...aminated with E.coli. A publicized incident was th...
...ences (AIIMS) has developed artificial testis, whi...r, underdeveloped genitals.// Doctors at the prem...ver 50 patients suffering from such problems, achi... "We are producing artificial testis and have trea...
...ed so high a priority in the minds of concerned he...here are moves to do away with regular school snac...are contributing to ungainly as well as dangerous ...the Institute of Medicine has been set up by the U...
Other Medicine News:Health News:National Infant Immunization Week Urges Parents to Vaccinate On Time 2Health News:U.S Officials Worried Over Failure In Preventing Food Contamination 2Health News:Artificial Testis Developed by AIIMS a Boon to Suffering Patients 2Health News:Weight Issues In Children-Experts Take Stock 2
(Date:12/3/2008)...swire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: BNVI...ompany,s,manufacturing and control process descri...onovo can move forward with the development of Men...ashes. , "We have concluded three CMC discu...e Agency,s recommendations for further development...
(Date:12/2/2008)... -- IBT Laboratories, a leading clinical-diagnost...g in immunology and allergy assays, announced that...nse of patients whose immune systems may be compro...chemotherapy drugs, or because they are taking imm...ansplant. The company launched the two new assays,...
(Date:12/1/2008)... A study has found that...que for imaging the breast, is not affected by eit...wo factors that limit the effectiveness of standar... will be presented today at the annual meeting of ... , , "The ability of PEM to detect cancer d...
(Date:12/1/2008)...reated With ENB-0040 at Children,s Hospital, Healt... Dec. 1 Enobia Pharma, an emerging...vel therapeutics for serious bone disorders, today...inical program for hypophosphatasia was dosed. Eno...RT) with ENB-0040 for the treatment of this rare a...
Breaking Medicine Technology:Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 1Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 2Omron Healthcare Introduces New Device Drivers Built on Microsoft HealthVault 21289 3ChanTest Launches Redesigned Web Site 5877 1ChanTest Launches Redesigned Web Site 5877 2Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 1Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 2Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 3Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 4Raptor Pharmaceuticals Corp Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease 5875 5LMXonline Offers Spanish Language Safety and Health Training Library 5873 1LMXonline Offers Spanish Language Safety and Health Training Library 5873 2
...unces Positive Top-Line Phase III Results for,Kepp...izures in,Paediatric Patients from One Month to Le...ril 20, 2007 - UCB today announced,positive top-li...zed, multi-centre, placebo-controlled study evalua...(levetiracetam) (20-50,mg/kg/day) as adjunctive th...
...dy Demonstrated the Clinical Potential of Peregrin...ere as Effective as,Avastin(R) in Animal Cancer Mo...irstCall/ --,Peregrine Pharmaceuticals, Inc. , a c... targeted monoclonal antibodies,for the treatment ...eported that data from multiple studies presented ...
Other Medicine Technology:UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 2UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 3UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 4UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7